Telomir Pharmaceuticals, Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TELO research report →
About the company
Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions. Its primary focus involves the development of TELOMIR-1, an innovative small molecule compound.
- CEO
- Erez Aminov
- IPO
- 2019
- Employees
- 1
- HQ
- Baltimore, FL, US
Price Chart
- Market Cap
- $43.66M
- P/E
- -4.32
- P/S
- 0.00
- P/B
- 8.80
- EV/EBITDA
- -4.15
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -201.23%
- ROIC
- -181.84%
- Revenue
- $0 · 0.00%
- Net Income
- $-10,413,205 · 37.01%
- EPS
- $-0.33 · 41.07%
- Op Income
- $-10,538,849
- FCF YoY
- 27.26%
- 52W High
- $3.10
- 52W Low
- $1.05
- 50D MA
- $1.29
- 200D MA
- $1.35
- Beta
- -0.24
- Avg Volume
- 152.68K
Get TickerSpark's AI analysis on TELO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 3, 26 | Mushak Andriy | other | 0 |
| May 21, 26 | Aminov Erez | other | 2,000,000 |
| May 21, 26 | Aminov Erez | other | 1,960,170 |
| May 21, 26 | Aminov Erez | sell | 2,000,000 |
| May 21, 26 | Aminov Erez | sell | 1,960,170 |
| May 21, 26 | Whalen Matthew Pratt | other | 25,000 |
| May 21, 26 | Whalen Matthew Pratt | sell | 25,000 |
| May 21, 26 | MacPherson Edward Clouston | other | 25,000 |
| May 21, 26 | MacPherson Edward Clouston | sell | 25,000 |
| May 21, 26 | Del Giudice Matthew Paul | other | 25,000 |
Our TELO coverage
Recent articles, reports, and earnings notes.
No research on TELO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TELO report →Similar companies
Peers in the same neighborhood.